

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.07156976 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.62655654 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.66889015 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.66889015 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.66889015 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.66889015 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.66889015 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.66889015 |
| 9 | respiratory burst (GO:0045730) | 4.22786958 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 4.19496206 |
| 11 | eosinophil chemotaxis (GO:0048245) | 3.98448846 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 3.86239785 |
| 13 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.84905343 |
| 14 | response to peptidoglycan (GO:0032494) | 3.82577491 |
| 15 | regulation of chronic inflammatory response (GO:0002676) | 3.79678520 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 3.77799469 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.73045460 |
| 18 | neutrophil activation (GO:0042119) | 3.64925739 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.64821570 |
| 20 | granulocyte activation (GO:0036230) | 3.61337417 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.58724776 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 3.56689620 |
| 23 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.56254652 |
| 24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.56074799 |
| 25 | eosinophil migration (GO:0072677) | 3.49594573 |
| 26 | myeloid cell activation involved in immune response (GO:0002275) | 3.49223337 |
| 27 | superoxide anion generation (GO:0042554) | 3.46505812 |
| 28 | cellular response to interferon-beta (GO:0035458) | 3.42898681 |
| 29 | positive regulation of antigen processing and presentation (GO:0002579) | 3.42503084 |
| 30 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.39903979 |
| 31 | phagosome maturation (GO:0090382) | 3.35830286 |
| 32 | cellular response to zinc ion (GO:0071294) | 3.33914788 |
| 33 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.33715062 |
| 34 | defense response to protozoan (GO:0042832) | 3.31861205 |
| 35 | B cell mediated immunity (GO:0019724) | 3.30201967 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.30128354 |
| 37 | signal peptide processing (GO:0006465) | 3.29496949 |
| 38 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.25878359 |
| 39 | microglial cell activation (GO:0001774) | 3.20787704 |
| 40 | reactive oxygen species biosynthetic process (GO:1903409) | 3.17855839 |
| 41 | response to interferon-beta (GO:0035456) | 3.17822017 |
| 42 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.14585444 |
| 43 | response to type I interferon (GO:0034340) | 3.12777670 |
| 44 | purine nucleotide salvage (GO:0032261) | 3.10150486 |
| 45 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.08467058 |
| 46 | negative regulation of interleukin-17 production (GO:0032700) | 3.08130616 |
| 47 | positive regulation of type 2 immune response (GO:0002830) | 3.08015256 |
| 48 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.07863287 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.06458253 |
| 50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05516342 |
| 51 | response to host immune response (GO:0052572) | 3.05516342 |
| 52 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.04983439 |
| 53 | cullin deneddylation (GO:0010388) | 3.04347338 |
| 54 | positive regulation of lymphocyte migration (GO:2000403) | 3.01814724 |
| 55 | negative regulation of mast cell activation (GO:0033004) | 3.01287687 |
| 56 | response to protozoan (GO:0001562) | 3.00383455 |
| 57 | regulation of podosome assembly (GO:0071801) | 3.00106560 |
| 58 | mast cell activation (GO:0045576) | 2.99940642 |
| 59 | proteasome assembly (GO:0043248) | 2.97224171 |
| 60 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.95298511 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 2.93118043 |
| 62 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91720195 |
| 63 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.90322162 |
| 64 | positive regulation of macrophage differentiation (GO:0045651) | 2.89328007 |
| 65 | protein deneddylation (GO:0000338) | 2.89269069 |
| 66 | monocyte chemotaxis (GO:0002548) | 2.87706478 |
| 67 | positive regulation of T cell migration (GO:2000406) | 2.86075041 |
| 68 | regulation of immunoglobulin secretion (GO:0051023) | 2.85629933 |
| 69 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.84685542 |
| 70 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82841368 |
| 71 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.81781291 |
| 72 | regulation of B cell differentiation (GO:0045577) | 2.81344166 |
| 73 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.81071364 |
| 74 | positive regulation of B cell differentiation (GO:0045579) | 2.80306132 |
| 75 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.78642613 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 2.78522716 |
| 77 | regulation of T cell migration (GO:2000404) | 2.77871980 |
| 78 | positive regulation of mast cell activation (GO:0033005) | 2.77822051 |
| 79 | myeloid dendritic cell activation (GO:0001773) | 2.76253296 |
| 80 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.76131203 |
| 81 | ATP synthesis coupled proton transport (GO:0015986) | 2.76131203 |
| 82 | T cell migration (GO:0072678) | 2.76046374 |
| 83 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.75841866 |
| 84 | response to thyroid hormone (GO:0097066) | 2.75043333 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 2.73974557 |
| 86 | regulation of mast cell activation (GO:0033003) | 2.73328662 |
| 87 | macrophage activation (GO:0042116) | 2.72522900 |
| 88 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.71869628 |
| 89 | regulation of lymphocyte migration (GO:2000401) | 2.71436543 |
| 90 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.71234280 |
| 91 | natural killer cell mediated immunity (GO:0002228) | 2.71234280 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.71211657 |
| 93 | amino sugar catabolic process (GO:0046348) | 2.70636401 |
| 94 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.69897761 |
| 95 | regulation of mononuclear cell migration (GO:0071675) | 2.68924252 |
| 96 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.68624369 |
| 97 | T-helper 1 type immune response (GO:0042088) | 2.66898120 |
| 98 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.65176601 |
| 99 | glycosphingolipid catabolic process (GO:0046479) | 2.65095011 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.65084062 |
| 101 | lymphocyte chemotaxis (GO:0048247) | 2.64620912 |
| 102 | negative regulation of viral genome replication (GO:0045071) | 2.63571351 |
| 103 | leukocyte aggregation (GO:0070486) | 2.63287845 |
| 104 | myeloid leukocyte activation (GO:0002274) | 2.62878291 |
| 105 | leukocyte mediated cytotoxicity (GO:0001909) | 2.61712793 |
| 106 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.60449646 |
| 107 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.60449646 |
| 108 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.60290477 |
| 109 | positive regulation of interleukin-10 production (GO:0032733) | 2.60283321 |
| 110 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.60255604 |
| 111 | regulation of vitamin metabolic process (GO:0030656) | 2.59825112 |
| 112 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.59526228 |
| 113 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.59414825 |
| 114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.59003610 |
| 115 | positive regulation of prostaglandin secretion (GO:0032308) | 2.58481808 |
| 116 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.58469788 |
| 117 | pinocytosis (GO:0006907) | 2.57816065 |
| 118 | regulation of activation of Janus kinase activity (GO:0010533) | 2.57085603 |
| 119 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.56856731 |
| 120 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.56818960 |
| 121 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.56818960 |
| 122 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.56818960 |
| 123 | oligosaccharide catabolic process (GO:0009313) | 2.56398482 |
| 124 | cellular extravasation (GO:0045123) | 2.56360971 |
| 125 | respiratory electron transport chain (GO:0022904) | 2.55594693 |
| 126 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.54968737 |
| 127 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.54941427 |
| 128 | response to host (GO:0075136) | 2.54892602 |
| 129 | response to host defenses (GO:0052200) | 2.54892602 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.54892602 |
| 131 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.54829460 |
| 132 | negative regulation of ligase activity (GO:0051352) | 2.54829460 |
| 133 | regulation of interleukin-12 production (GO:0032655) | 2.54355614 |
| 134 | leukocyte degranulation (GO:0043299) | 2.53933474 |
| 135 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.53206613 |
| 136 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.52297876 |
| 137 | type I interferon signaling pathway (GO:0060337) | 2.51678184 |
| 138 | cellular response to type I interferon (GO:0071357) | 2.51678184 |
| 139 | regulation of chemokine biosynthetic process (GO:0045073) | 2.51503592 |
| 140 | regulation of prostaglandin secretion (GO:0032306) | 2.50239173 |
| 141 | positive regulation of heat generation (GO:0031652) | 2.50099702 |
| 142 | platelet dense granule organization (GO:0060155) | 2.49831414 |
| 143 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.49488193 |
| 144 | electron transport chain (GO:0022900) | 2.49371241 |
| 145 | positive regulation of interferon-beta production (GO:0032728) | 2.49214580 |
| 146 | neutrophil mediated immunity (GO:0002446) | 2.49129196 |
| 147 | protein complex biogenesis (GO:0070271) | 2.48935785 |
| 148 | positive regulation of mast cell degranulation (GO:0043306) | 2.48656817 |
| 149 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.48656817 |
| 150 | phagocytosis, engulfment (GO:0006911) | 2.48290249 |
| 151 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.47477029 |
| 152 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.45511910 |
| 153 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.45511910 |
| 154 | heme biosynthetic process (GO:0006783) | 2.45317449 |
| 155 | positive regulation of defense response to virus by host (GO:0002230) | 2.44090845 |
| 156 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.42464720 |
| 157 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.42357468 |
| 158 | dendritic cell differentiation (GO:0097028) | 2.42315434 |
| 159 | response to interferon-gamma (GO:0034341) | 2.41886076 |
| 160 | purine-containing compound salvage (GO:0043101) | 2.40744482 |
| 161 | chaperone-mediated protein transport (GO:0072321) | 2.39792726 |
| 162 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.39601536 |
| 163 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.38968539 |
| 164 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.38696276 |
| 165 | cellular response to interferon-gamma (GO:0071346) | 2.38181836 |
| 166 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.38077167 |
| 167 | regulation of growth of symbiont in host (GO:0044126) | 2.38077167 |
| 168 | negative regulation of growth of symbiont in host (GO:0044130) | 2.38077167 |
| 169 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.38077167 |
| 170 | oxidative phosphorylation (GO:0006119) | 2.37424032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.96864061 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.43242381 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.36838635 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.12017984 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.34561020 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.14362223 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03379783 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02560321 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.85148795 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.79266939 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.69765411 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69146195 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.60876180 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.53966429 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.52275179 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.47751379 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.44181978 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43721330 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.40767945 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.40068629 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34107973 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.33476085 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16290918 |
| 24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.15302964 |
| 25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.12372583 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.09586248 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.08242711 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06046449 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05489393 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.94729713 |
| 31 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.89523997 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.81062865 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77423841 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75880650 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75432384 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.70268592 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.66414485 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64223011 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63799870 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61668493 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61512570 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59945065 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.57896011 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55003830 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51664342 |
| 46 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.51390007 |
| 47 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50053189 |
| 48 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.49896832 |
| 49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.49345609 |
| 50 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.48554708 |
| 51 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.48109499 |
| 52 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.47373836 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.43697288 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43512521 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42613045 |
| 56 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41455932 |
| 57 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.40553199 |
| 58 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.37802493 |
| 59 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.37491034 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37209602 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37068723 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35546868 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33650416 |
| 64 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.32019886 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28638894 |
| 66 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.28502972 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.27211922 |
| 68 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26853127 |
| 69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24419110 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22446281 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19502764 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19249371 |
| 73 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18732230 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17982511 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17112612 |
| 76 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.15758369 |
| 77 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15110112 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13310244 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12975996 |
| 80 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.11770790 |
| 81 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10860531 |
| 82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10840249 |
| 83 | MYB_26560356_Chip-Seq_TH1_Human | 1.10736181 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10222354 |
| 85 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09924029 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09891934 |
| 87 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08329993 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07951129 |
| 89 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06242405 |
| 90 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.05838015 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04944886 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04222968 |
| 93 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.04000764 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03837391 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01394610 |
| 96 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00439989 |
| 97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99833747 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99282991 |
| 99 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.97172655 |
| 100 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97141697 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97039503 |
| 102 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.97027289 |
| 103 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96703841 |
| 104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96604111 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96269982 |
| 106 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94622781 |
| 107 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94329942 |
| 108 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94174026 |
| 109 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94083158 |
| 110 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93177026 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88933231 |
| 112 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.88401344 |
| 113 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87942570 |
| 114 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.87242257 |
| 115 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86604974 |
| 116 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86452647 |
| 117 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.83687737 |
| 118 | MAF_26560356_Chip-Seq_TH1_Human | 0.83671338 |
| 119 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83132355 |
| 120 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83013572 |
| 121 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82429771 |
| 122 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.81362045 |
| 123 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81187851 |
| 124 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.80504557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.77649775 |
| 2 | MP0009785_altered_susceptibility_to | 3.64690523 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.63278996 |
| 4 | MP0006082_CNS_inflammation | 3.41232136 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.36947298 |
| 6 | MP0003436_decreased_susceptibility_to | 3.22701709 |
| 7 | MP0003724_increased_susceptibility_to | 3.22549754 |
| 8 | MP0005671_abnormal_response_to | 3.22203370 |
| 9 | MP0002419_abnormal_innate_immunity | 3.06927216 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.99937123 |
| 11 | MP0005025_abnormal_response_to | 2.80906934 |
| 12 | MP0001790_abnormal_immune_system | 2.59238151 |
| 13 | MP0005387_immune_system_phenotype | 2.59238151 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.51008041 |
| 15 | MP0002723_abnormal_immune_serum | 2.42069093 |
| 16 | MP0001800_abnormal_humoral_immune | 2.34030813 |
| 17 | MP0000685_abnormal_immune_system | 2.30949303 |
| 18 | MP0001819_abnormal_immune_cell | 2.23833918 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.23522855 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.19540364 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.03406630 |
| 22 | MP0002405_respiratory_system_inflammati | 1.95624185 |
| 23 | MP0003186_abnormal_redox_activity | 1.94175208 |
| 24 | MP0004510_myositis | 1.93811052 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.92763461 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 1.86160443 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.85143899 |
| 28 | MP0001853_heart_inflammation | 1.83355058 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.77163085 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.77059505 |
| 31 | MP0000343_altered_response_to | 1.74082709 |
| 32 | MP0009764_decreased_sensitivity_to | 1.69002101 |
| 33 | MP0008469_abnormal_protein_level | 1.68191048 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.67969678 |
| 35 | MP0000716_abnormal_immune_system | 1.64347295 |
| 36 | MP0005310_abnormal_salivary_gland | 1.60094408 |
| 37 | MP0002398_abnormal_bone_marrow | 1.55690820 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.50672692 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.48400510 |
| 40 | MP0002006_tumorigenesis | 1.45592300 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.43468658 |
| 42 | MP0003303_peritoneal_inflammation | 1.41090349 |
| 43 | MP0002429_abnormal_blood_cell | 1.40584949 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.37175610 |
| 45 | MP0009840_abnormal_foam_cell | 1.37080844 |
| 46 | MP0003448_altered_tumor_morphology | 1.36591843 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.35997889 |
| 48 | MP0003763_abnormal_thymus_physiology | 1.34889180 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.33194525 |
| 50 | MP0005165_increased_susceptibility_to | 1.29620442 |
| 51 | MP0002722_abnormal_immune_system | 1.29340647 |
| 52 | MP0000858_altered_metastatic_potential | 1.28279975 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.24972279 |
| 54 | MP0000604_amyloidosis | 1.24860296 |
| 55 | MP0003195_calcinosis | 1.23177028 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.22486518 |
| 57 | MP0008260_abnormal_autophagy | 1.18262941 |
| 58 | MP0005451_abnormal_body_composition | 1.14950575 |
| 59 | MP0004147_increased_porphyrin_level | 1.14818625 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.14239599 |
| 61 | MP0004947_skin_inflammation | 1.13838844 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.11839212 |
| 63 | MP0002254_reproductive_system_inflammat | 1.11333415 |
| 64 | MP0009765_abnormal_xenobiotic_induced | 1.10539485 |
| 65 | MP0003075_altered_response_to | 1.05916842 |
| 66 | MP0002933_joint_inflammation | 1.04713818 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.04603682 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.04603682 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.04187231 |
| 70 | MP0005164_abnormal_response_to | 1.02828597 |
| 71 | MP0003690_abnormal_glial_cell | 1.00452077 |
| 72 | MP0005166_decreased_susceptibility_to | 1.00141441 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 0.98656900 |
| 74 | MP0001542_abnormal_bone_strength | 0.96747404 |
| 75 | MP0002876_abnormal_thyroid_physiology | 0.95190565 |
| 76 | MP0009763_increased_sensitivity_to | 0.95053950 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.94156444 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.91818778 |
| 79 | MP0000372_irregular_coat_pigmentation | 0.89750333 |
| 80 | MP0002132_abnormal_respiratory_system | 0.88884113 |
| 81 | MP0008004_abnormal_stomach_pH | 0.88146500 |
| 82 | MP0000490_abnormal_crypts_of | 0.87721895 |
| 83 | MP0001727_abnormal_embryo_implantation | 0.85537440 |
| 84 | MP0006035_abnormal_mitochondrial_morpho | 0.84997272 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.84347977 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 0.84268062 |
| 87 | MP0001764_abnormal_homeostasis | 0.82955522 |
| 88 | MP0005171_absent_coat_pigmentation | 0.82585263 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.81854674 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.80456892 |
| 91 | MP0009278_abnormal_bone_marrow | 0.80053375 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.79832528 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78918710 |
| 94 | MP0003646_muscle_fatigue | 0.78168282 |
| 95 | MP0006054_spinal_hemorrhage | 0.77368815 |
| 96 | MP0005408_hypopigmentation | 0.76452512 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75623579 |
| 98 | MP0000920_abnormal_myelination | 0.74451508 |
| 99 | MP0003866_abnormal_defecation | 0.73899742 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.73520142 |
| 101 | MP0005390_skeleton_phenotype | 0.73518978 |
| 102 | MP0000358_abnormal_cell_content/ | 0.72891094 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.71645866 |
| 104 | MP0001873_stomach_inflammation | 0.71618112 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.70679898 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.70636288 |
| 107 | MP0004883_abnormal_blood_vessel | 0.70625360 |
| 108 | MP0005266_abnormal_metabolism | 0.70287639 |
| 109 | MP0008058_abnormal_DNA_repair | 0.70275815 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.70257060 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.69633552 |
| 112 | MP0001663_abnormal_digestive_system | 0.68363064 |
| 113 | MP0002163_abnormal_gland_morphology | 0.67972547 |
| 114 | MP0000609_abnormal_liver_physiology | 0.67163189 |
| 115 | MP0005535_abnormal_body_temperature | 0.65505559 |
| 116 | MP0003786_premature_aging | 0.65120968 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.64817129 |
| 118 | MP0001851_eye_inflammation | 0.63684197 |
| 119 | MP0000249_abnormal_blood_vessel | 0.62558410 |
| 120 | MP0000681_abnormal_thyroid_gland | 0.62557660 |
| 121 | MP0005636_abnormal_mineral_homeostasis | 0.61491254 |
| 122 | MP0001881_abnormal_mammary_gland | 0.61088247 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.60450106 |
| 124 | MP0005647_abnormal_sex_gland | 0.60232686 |
| 125 | MP0008873_increased_physiological_sensi | 0.59173212 |
| 126 | MP0003795_abnormal_bone_structure | 0.59064411 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.57547814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.40289999 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.68472047 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 5.37922097 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.07347665 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.45293184 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.43560998 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.84306277 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.77334378 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.75434863 |
| 10 | Recurrent skin infections (HP:0001581) | 3.59488685 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.43538395 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.40811513 |
| 13 | Myositis (HP:0100614) | 3.38385667 |
| 14 | Obstructive lung disease (HP:0006536) | 3.29946969 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29946969 |
| 16 | Stomatitis (HP:0010280) | 3.21433509 |
| 17 | Gingivitis (HP:0000230) | 3.13994099 |
| 18 | Petechiae (HP:0000967) | 3.09499624 |
| 19 | Orchitis (HP:0100796) | 3.07677934 |
| 20 | Axonal loss (HP:0003447) | 3.07455453 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.05684020 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.02719164 |
| 23 | Optic neuritis (HP:0100653) | 3.02719164 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.97321961 |
| 25 | Hepatosplenomegaly (HP:0001433) | 2.93037619 |
| 26 | Basal ganglia calcification (HP:0002135) | 2.87336075 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84195363 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84195363 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84195363 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 2.80928957 |
| 31 | Increased serum ferritin (HP:0003281) | 2.75464247 |
| 32 | Acute necrotizing encephalopathy (HP:0006965) | 2.71439715 |
| 33 | Mitochondrial inheritance (HP:0001427) | 2.71378728 |
| 34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.70500066 |
| 35 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.68949195 |
| 36 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.68949195 |
| 37 | Agnosia (HP:0010524) | 2.68483093 |
| 38 | Progressive neurologic deterioration (HP:0002344) | 2.68177967 |
| 39 | IgM deficiency (HP:0002850) | 2.60230650 |
| 40 | Mutism (HP:0002300) | 2.57940930 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.57447667 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.57447667 |
| 43 | Increased IgM level (HP:0003496) | 2.57007106 |
| 44 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.56882978 |
| 45 | Recurrent viral infections (HP:0004429) | 2.53478501 |
| 46 | Purpura (HP:0000979) | 2.49897829 |
| 47 | Respiratory failure (HP:0002878) | 2.47794137 |
| 48 | 3-Methylglutaconic aciduria (HP:0003535) | 2.47640115 |
| 49 | Hepatocellular necrosis (HP:0001404) | 2.45862997 |
| 50 | Increased muscle lipid content (HP:0009058) | 2.45591006 |
| 51 | Urticaria (HP:0001025) | 2.44104123 |
| 52 | Prostate neoplasm (HP:0100787) | 2.43419162 |
| 53 | Poor head control (HP:0002421) | 2.42001169 |
| 54 | Hypertensive crisis (HP:0100735) | 2.41235096 |
| 55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.40561971 |
| 56 | Vasculitis (HP:0002633) | 2.39947720 |
| 57 | Nuclear cataract (HP:0100018) | 2.36183702 |
| 58 | Increased hepatocellular lipid droplets (HP:0006565) | 2.36004954 |
| 59 | Exertional dyspnea (HP:0002875) | 2.35987084 |
| 60 | Meningitis (HP:0001287) | 2.35613601 |
| 61 | Increased CSF lactate (HP:0002490) | 2.33736817 |
| 62 | Hepatic necrosis (HP:0002605) | 2.31783298 |
| 63 | Cerebral edema (HP:0002181) | 2.31368075 |
| 64 | Acute encephalopathy (HP:0006846) | 2.30981521 |
| 65 | Abnormality of the prostate (HP:0008775) | 2.30344514 |
| 66 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.29770671 |
| 67 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.29770671 |
| 68 | Abnormal protein glycosylation (HP:0012346) | 2.29770671 |
| 69 | Abnormal glycosylation (HP:0012345) | 2.29770671 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.29724390 |
| 71 | Lactic acidosis (HP:0003128) | 2.29600150 |
| 72 | Severe combined immunodeficiency (HP:0004430) | 2.29187257 |
| 73 | Nausea (HP:0002018) | 2.28641961 |
| 74 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.28295031 |
| 75 | Degeneration of anterior horn cells (HP:0002398) | 2.28176945 |
| 76 | Abnormality of the anterior horn cell (HP:0006802) | 2.28176945 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.27844871 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 2.26623005 |
| 79 | Recurrent pneumonia (HP:0006532) | 2.25040078 |
| 80 | Leukocytosis (HP:0001974) | 2.24622659 |
| 81 | Renal Fanconi syndrome (HP:0001994) | 2.24087787 |
| 82 | Increased serum pyruvate (HP:0003542) | 2.22880204 |
| 83 | Abnormality of T cell number (HP:0011839) | 2.22827035 |
| 84 | Pustule (HP:0200039) | 2.19727426 |
| 85 | Disinhibition (HP:0000734) | 2.18583881 |
| 86 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.18215748 |
| 87 | Progressive macrocephaly (HP:0004481) | 2.14562865 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.14504864 |
| 89 | CNS demyelination (HP:0007305) | 2.14378602 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.12039379 |
| 91 | Amyloidosis (HP:0011034) | 2.11973010 |
| 92 | Increased serum lactate (HP:0002151) | 2.11415423 |
| 93 | Glomerulonephritis (HP:0000099) | 2.11088085 |
| 94 | T lymphocytopenia (HP:0005403) | 2.10257822 |
| 95 | Lipid accumulation in hepatocytes (HP:0006561) | 2.08704322 |
| 96 | Exercise intolerance (HP:0003546) | 2.08038423 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.07998386 |
| 98 | Cholecystitis (HP:0001082) | 2.07998386 |
| 99 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.07736689 |
| 100 | Periodontitis (HP:0000704) | 2.07029969 |
| 101 | Thyroiditis (HP:0100646) | 2.06656940 |
| 102 | Ragged-red muscle fibers (HP:0003200) | 2.05918592 |
| 103 | Abnormality of glycolysis (HP:0004366) | 2.05612889 |
| 104 | Pulmonary infiltrates (HP:0002113) | 2.04858052 |
| 105 | Anorexia (HP:0002039) | 2.04556264 |
| 106 | Pathologic fracture (HP:0002756) | 2.04442253 |
| 107 | Bone cyst (HP:0012062) | 2.04171100 |
| 108 | Osteomyelitis (HP:0002754) | 2.03516534 |
| 109 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02561028 |
| 110 | Mucopolysacchariduria (HP:0008155) | 2.02561028 |
| 111 | Esophageal neoplasm (HP:0100751) | 2.02078318 |
| 112 | Neoplasm of head and neck (HP:0012288) | 2.02078318 |
| 113 | Increased intramyocellular lipid droplets (HP:0012240) | 2.00872869 |
| 114 | Type I transferrin isoform profile (HP:0003642) | 1.99443885 |
| 115 | Chronic diarrhea (HP:0002028) | 1.98416457 |
| 116 | Gangrene (HP:0100758) | 1.96895269 |
| 117 | Abnormality of T cells (HP:0002843) | 1.95931846 |
| 118 | Polyneuropathy (HP:0001271) | 1.95561898 |
| 119 | Dicarboxylic aciduria (HP:0003215) | 1.95171832 |
| 120 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95171832 |
| 121 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95170161 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94067116 |
| 123 | IgG deficiency (HP:0004315) | 1.92539496 |
| 124 | Cellulitis (HP:0100658) | 1.92176750 |
| 125 | Vertebral compression fractures (HP:0002953) | 1.92049858 |
| 126 | Abnormality of eosinophils (HP:0001879) | 1.92017524 |
| 127 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91301144 |
| 128 | Thrombocytosis (HP:0001894) | 1.88478916 |
| 129 | Encephalitis (HP:0002383) | 1.88143533 |
| 130 | Loss of speech (HP:0002371) | 1.87589018 |
| 131 | Prolonged neonatal jaundice (HP:0006579) | 1.86729179 |
| 132 | Chronic otitis media (HP:0000389) | 1.86152156 |
| 133 | Keratoconjunctivitis sicca (HP:0001097) | 1.83344388 |
| 134 | Hypergammaglobulinemia (HP:0010702) | 1.82598197 |
| 135 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82222469 |
| 136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82222469 |
| 137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82222469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.32033209 |
| 2 | BLK | 3.30540765 |
| 3 | MAP3K14 | 3.18673320 |
| 4 | MAP3K12 | 2.99517355 |
| 5 | NME2 | 2.93990590 |
| 6 | RIPK4 | 2.87058443 |
| 7 | PBK | 2.85946149 |
| 8 | IRAK4 | 2.84610508 |
| 9 | TXK | 2.68029618 |
| 10 | CAMKK2 | 2.67615863 |
| 11 | NEK9 | 2.66511816 |
| 12 | TBK1 | 2.51045934 |
| 13 | MAP4K1 | 2.48537637 |
| 14 | BCKDK | 2.35725922 |
| 15 | PDK2 | 2.24145543 |
| 16 | MST4 | 2.21479126 |
| 17 | PIM2 | 2.17428445 |
| 18 | KIT | 1.98821741 |
| 19 | IRAK3 | 1.85406283 |
| 20 | TYK2 | 1.82943075 |
| 21 | EIF2AK1 | 1.80832369 |
| 22 | TEC | 1.80112716 |
| 23 | JAK3 | 1.74908614 |
| 24 | IKBKE | 1.68511621 |
| 25 | EIF2AK3 | 1.65609822 |
| 26 | IKBKB | 1.61429106 |
| 27 | GRK7 | 1.58475547 |
| 28 | BMPR2 | 1.52010627 |
| 29 | SYK | 1.47072034 |
| 30 | NEK1 | 1.43148583 |
| 31 | ARAF | 1.42800814 |
| 32 | STK16 | 1.34131257 |
| 33 | CSF1R | 1.30089145 |
| 34 | LYN | 1.28479345 |
| 35 | BTK | 1.27478131 |
| 36 | ZAP70 | 1.25599169 |
| 37 | BUB1 | 1.25275594 |
| 38 | MAP3K3 | 1.19869684 |
| 39 | KDR | 1.17828562 |
| 40 | BMPR1B | 1.14660560 |
| 41 | CDK19 | 1.14614452 |
| 42 | MAP4K2 | 1.13168678 |
| 43 | ABL2 | 1.10967874 |
| 44 | LCK | 1.08481251 |
| 45 | MAP3K13 | 1.08283542 |
| 46 | CCNB1 | 1.08176354 |
| 47 | EIF2AK2 | 1.03221014 |
| 48 | MYLK | 1.03121939 |
| 49 | MAP3K11 | 0.98856826 |
| 50 | CAMK1D | 0.97109851 |
| 51 | CDK8 | 0.95871069 |
| 52 | SIK3 | 0.89321588 |
| 53 | MOS | 0.89159724 |
| 54 | DAPK1 | 0.85800595 |
| 55 | PIM1 | 0.85293292 |
| 56 | MAP3K5 | 0.84923711 |
| 57 | ADRBK2 | 0.83832440 |
| 58 | OXSR1 | 0.83048746 |
| 59 | MAP2K3 | 0.82113979 |
| 60 | YES1 | 0.81383933 |
| 61 | DDR2 | 0.77098174 |
| 62 | CASK | 0.77009763 |
| 63 | TRPM7 | 0.76752196 |
| 64 | CSK | 0.76712026 |
| 65 | ERN1 | 0.76485316 |
| 66 | CLK1 | 0.76019018 |
| 67 | TGFBR2 | 0.75739629 |
| 68 | TAOK3 | 0.74924346 |
| 69 | PRKCD | 0.74471331 |
| 70 | JAK1 | 0.73856184 |
| 71 | MUSK | 0.72867574 |
| 72 | CSNK1G3 | 0.72199973 |
| 73 | TESK2 | 0.70404668 |
| 74 | SCYL2 | 0.66971186 |
| 75 | FGR | 0.65552203 |
| 76 | ITK | 0.65230318 |
| 77 | TESK1 | 0.64956325 |
| 78 | STK4 | 0.64225946 |
| 79 | ZAK | 0.63975985 |
| 80 | TLK1 | 0.62691825 |
| 81 | HCK | 0.61917138 |
| 82 | MARK3 | 0.61854856 |
| 83 | VRK1 | 0.61666476 |
| 84 | ILK | 0.56503506 |
| 85 | ACVR1B | 0.55566178 |
| 86 | MATK | 0.52431621 |
| 87 | RPS6KA4 | 0.51927918 |
| 88 | JAK2 | 0.50551020 |
| 89 | PAK1 | 0.49349505 |
| 90 | TIE1 | 0.47411738 |
| 91 | BRSK2 | 0.47240737 |
| 92 | DAPK3 | 0.46263990 |
| 93 | LIMK1 | 0.46239056 |
| 94 | CAMKK1 | 0.45057628 |
| 95 | PRKCQ | 0.44833107 |
| 96 | TSSK6 | 0.44830048 |
| 97 | PAK4 | 0.43109164 |
| 98 | SRPK1 | 0.42878898 |
| 99 | TRIM28 | 0.41221046 |
| 100 | STK24 | 0.40920674 |
| 101 | STK10 | 0.40819439 |
| 102 | PRPF4B | 0.40082056 |
| 103 | FES | 0.39900467 |
| 104 | LRRK2 | 0.39588496 |
| 105 | PLK4 | 0.39047432 |
| 106 | TAOK2 | 0.38867056 |
| 107 | MAP2K6 | 0.38100833 |
| 108 | CSNK1G2 | 0.37881763 |
| 109 | CSNK1A1L | 0.37784520 |
| 110 | NME1 | 0.37241161 |
| 111 | CHUK | 0.36861811 |
| 112 | ABL1 | 0.36081691 |
| 113 | PLK2 | 0.34703512 |
| 114 | NUAK1 | 0.33940068 |
| 115 | CSNK2A1 | 0.33492192 |
| 116 | MAP3K1 | 0.33348876 |
| 117 | GRK6 | 0.33244542 |
| 118 | RPS6KA5 | 0.32426286 |
| 119 | AURKA | 0.32423951 |
| 120 | TAOK1 | 0.32263720 |
| 121 | MAPKAPK5 | 0.31170963 |
| 122 | GRK5 | 0.30934165 |
| 123 | MAPKAPK2 | 0.30531800 |
| 124 | IRAK2 | 0.30061889 |
| 125 | RPS6KA6 | 0.29971151 |
| 126 | CSNK2A2 | 0.29370785 |
| 127 | EGFR | 0.28652978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.07525214 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.82583789 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61334725 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.56882525 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.52074246 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.51950192 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.50917165 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.41843071 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.36163407 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.28331426 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.27773702 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 2.17116839 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 2.14047183 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.03738331 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.95257473 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.86543733 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.76495996 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.74885851 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74863948 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.72530841 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70288755 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68953939 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.65991353 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.65567907 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.65457263 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.64555889 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63019785 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60424263 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59461191 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58671376 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53246207 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.52810943 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.51879439 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47560605 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42358603 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39554584 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38873348 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38156527 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31907791 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.30546644 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.24599171 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.21137322 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19234370 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.18534400 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15441761 |
| 46 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12549558 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03788727 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.03661606 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.00202889 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 0.99679812 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.99470931 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 0.94302220 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90631291 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 0.88597238 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86756118 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 0.86364428 |
| 57 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.84616444 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84390981 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82164373 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82151094 |
| 61 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.79542587 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76928299 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76746922 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76253371 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73654474 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71605288 |
| 67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71054464 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70823787 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70201919 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69490736 |
| 71 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.69240869 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68716097 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68572396 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.67173167 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65055094 |
| 76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.64754996 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64346547 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63917135 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63754442 |
| 80 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63714049 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62840943 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59751420 |
| 83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59553729 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59115331 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58946053 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58388072 |
| 87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57228668 |
| 88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56631568 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55521083 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54809736 |
| 91 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54602837 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54278214 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53277192 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52871552 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51001670 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48169653 |
| 97 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46935001 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46428918 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45122651 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42642478 |
| 101 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42381116 |
| 102 | Hepatitis B_Homo sapiens_hsa05161 | 0.41256291 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41064443 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.41000913 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39665438 |
| 106 | Spliceosome_Homo sapiens_hsa03040 | 0.38620711 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38564193 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37857523 |
| 109 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37769149 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34361859 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33851719 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33716271 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30915638 |
| 114 | Purine metabolism_Homo sapiens_hsa00230 | 0.30643447 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30212456 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | 0.30182205 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24830541 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.23311958 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.23044517 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22512460 |

